The NF-κB signaling pathway mediated by TNF-α can regulate lipid metabolism, and IL-6 can promote systemic inflammation, leading to metabolic syndrome and abnormal lipid metabolism (Engin, 2017; Wang and He, 2018). Here, NFKB1 is linked to metabolic syndrome.